Home › Anika Therapeutics, Inc. › Merogel Injectable
Merogel Injectable
Anika Therapeutics, Inc. · Model 640-023 · UDI-DI 08033549790769
10
510(k) clearances
175
Adverse events
15
Recalls
35
Facilities
Description
MEROGEL Injectable is a bioresorbable nasal dressing and sinus stent and otologic gel designed to help control bleeding and to create a physical separation of mucosal surfaces with the purpose of preventing adhesions during the post-operative healing process
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.